Clinical trial
A Phase 3, Multi-Center, Randomized, Placebo Controlled Study of PHP When Administered by Continuous Infusion in Patients With Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)
NCT00021502 is registered in ClinicalTrials.gov with Apex Bioscience as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Multi-Center, Randomized, Placebo Controlled Study of PHP When Administered by Continuous Infusion in Patients With Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)
- Lead sponsor
- Apex Bioscience
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2001
- Completion date
- May 31, 2004
- Enrollment
- 1,000
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.